ADC Therapeutics
ADCT
ADCT
66 hedge funds and large institutions have $177M invested in ADC Therapeutics in 2022 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
35% less capital invested
Capital invested by funds: $273M → $177M (-$96.2M)
57% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 21
69% less call options, than puts
Call options by funds: $75K | Put options by funds: $241K
Holders
66
Holding in Top 10
1
Calls
$75K
Puts
$241K
Top Buyers
| 1 | +$11.5M | |
| 2 | +$3.54M | |
| 3 | +$1.75M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
+$1.19M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$1.11M |
Top Sellers
| 1 | -$3.71M | |
| 2 | -$2.71M | |
| 3 | -$1.23M | |
| 4 |
Walleye Capital
New York
|
-$928K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$684K |